Skip to content

Clinical and Histological Evaluation of Subepithelial Connective Tissue Graft Maturation at Different Healing Timepoints, With and Without Topical Application of a Polynucleotide- and Hyaluronic Acid-Based Gel

Clinical and Histological Evaluation of Subepithelial Connective Tissue Graft Maturation at Different Healing Timepoints, With and Without Topical Application of a Polynucleotide- and Hyaluronic Acid-Based Gel: A Randomized, Blinded, Controlled Clinical Trial With a Split-Mouth Design

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07708051
Enrollment
15
Registered
2026-07-16
Start date
2026-07-01
Completion date
2027-02-27
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession, Generalized, Gingival Recession, Localized, Palate; Wound, Wound Healing

Keywords

Subepithelial connective tissue graft, Palatal donor site, Wound healing, Gingival Recession, Hyaluronic acid, Polynucleotides, Split-mouth clinical trial, Histological analysis

Brief summary

This study evaluates whether a 9-week healing interval is sufficient for subepithelial connective tissue graft (SCTG) maturation after palatal harvesting, and whether topical application of a polynucleotide and hyaluronic acid gel (Regenfast®) improves tissue quality. This is a randomized, blinded, controlled clinical trial with a split-mouth design involving 15 participants. Each participant undergoes bilateral SCTG harvesting from the palate in two surgical sessions 9 weeks apart. In the first session, one randomized side receives a single topical application of Regenfast® after graft removal; the contralateral side serves as control. Standardized tissue fragments (3×3 mm, 1.5 mm thickness) are collected from each graft for histological (HE, Picrosirius Red) and immunohistochemical analyses. Comparisons are made between grafts collected at baseline and after 9 weeks, and between sides treated with or without the gel.

Detailed description

Surgical procedures and sample collections will be performed at Instituto Kahn Odontologia (Rio de Janeiro, Brazil). Laboratory analyses will be conducted at the Histology Laboratory of the School of Dentistry of Ribeirao Preto, University of Sao Paulo (FORP-USP). SCTG removal will be performed using the double incision technique (Harris, 2003) with a standardized 1.5 mm guide scalpel, under local anesthesia (2% lidocaine, 1:100,000 epinephrine). From each graft, a standardized fragment (3×3 mm, 1.5 mm thickness) will be collected from the distal portion and immediately fixed in 10% buffered formalin for 24-48 hours, then transferred to 70% alcohol. Laboratory analyses will include: (1) Hematoxylin-eosin (HE) for general morphological assessment; (2) Picrosirius Red under polarized light for quantification of collagen density and proportion of type I and type III collagen fibers; (3) Immunohistochemistry for vascularization assessment, measuring microvessel density (n/mm²) and vascular area (%). Statistical analysis will use paired Student's t-test or Wilcoxon test for paired samples, depending on data distribution (Shapiro-Wilk test), with significance level of 5% (p\<0.05).

Interventions

DRUGpolynucleotide and hyaluronic acid gel

Single topical application of polynucleotide and hyaluronic acid gel (Regenfast, 0.3 ml) to the palatal donor site immediately after subepithelial connective tissue graft harvesting in the first surgical session, before suturing.

PROCEDUREsubepithelial connective tissue graft harvesting

Bilateral subepithelial connective tissue graft harvesting from the palatal donor site using the double incision technique (Harris, 2003) with a standardized 1.5 mm guide scalpel, under local anesthesia (2% lidocaine with 1:100,000 epinephrine). Performed in two surgical sessions with a 9-week interval.

Sponsors

University of Sao Paulo
Lead SponsorOTHER
Instituto Kahn Odontologia
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Participant and care provider (surgeon performing graft collection) are blinded to side allocation. Outcomes assessors performing histological and immunohistochemical analyses are blinded throughout the study. The investigator responsible for topical application of Regenfast® is not blinded, as they must apply the gel to the assigned side immediately after graft removal.

Intervention model description

Split-mouth design in which each participant contributes two simultaneous treatment sites (left and right palate). One randomized side receives a single topical application of Regenfast® (polynucleotide and hyaluronic acid gel) after the first SCTG harvest; the contralateral side receives no intervention and serves as control. Both sides are harvested again after 9 weeks, allowing paired intraindividual comparisons.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 60 years * Good general systemic health * Presence of multiple bilateral gingival recessions with indication for root coverage

Exclusion criteria

* Smoking of any intensity * Pregnancy or lactation * Oral lesions or alterations in the palatal mucosa * Previous history of graft harvesting from the donor area * Continuous use of medications that interfere with the inflammatory response, such as corticosteroids or immunosuppressants * Autoimmune diseases, coagulation disorders, or other systemic conditions affecting wound healing

Design outcomes

Primary

MeasureTime frameDescription
Histological Tissue Architecture of the Subepithelial Connective Tissue GraftBaseline and 9 weeks after initial graft harvestingMorphological evaluation of tissue architecture using hematoxylin-eosin (HE) staining, assessing cellular organization, connective tissue maturation, and overall structural quality of grafts harvested at baseline and 9 weeks after initial harvesting, with and without topical application of polynucleotide and hyaluronic acid gel (Regenfast®).
Collagen Density and Fiber Maturation of the Subepithelial Connective Tissue GraftBaseline and 9 weeks after initial graft harvestingQuantification of collagen density and proportion of type I and type III collagen fibers using Picrosirius Red staining under polarized light microscopy, comparing grafts harvested at baseline and 9 weeks after initial harvesting, with and without topical application of polynucleotide and hyaluronic acid gel (Regenfast®).
Microvascular Density and Vascular Area of the Subepithelial Connective Tissue GraftBaseline and 9 weeks after initial graft harvestingImmunohistochemical evaluation of vascularization, assessing microvessel density (number/mm²) and vascular area (%) of grafts harvested at baseline and 9 weeks after initial harvesting, with and without topical application of polynucleotide and hyaluronic acid gel (Regenfast®).

Contacts

CONTACTMarcella Kahn, DDS, MS Candidate
mbkahn@usp.br+5521988483846
CONTACTMichel Reis Messora, DDS, MS, PhD
m.messora@forp.usp.br
PRINCIPAL_INVESTIGATORMarcella B Kahn, DDS, MS Candidate

Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo (FORP-USP)

STUDY_CHAIRMichel Reis Messora, DDS, MS, PhD

Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo (FORP-USP) Role: Study Chair

STUDY_DIRECTORSergio Kahn, DDS, MS, PhD

Instituto Kahn Odontologia, Rio de Janeiro

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026